Literature DB >> 5551485

Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect.

S H Curry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5551485      PMCID： PMC1811516     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  8 in total

1.  NON-POLAR URINARY METABOLITES OF CHLORPROMAZINE IN MALE SCHIZOPHRENICS.

Authors:  R M ROSE; A DIMASCIO; G L KLERMAN
Journal:  J Psychiatr Res       Date:  1964-12       Impact factor: 4.791

2.  FURTHER STUDIES OF CHLORPROMAZINE METABOLISM AND RELAPSE RATE.

Authors:  A A KURLAND; C L HUANG; K J HALLAM; T E HANLON
Journal:  J Psychiatr Res       Date:  1965-05       Impact factor: 4.791

3.  Dose effects of chlorpromazine on human sleep.

Authors:  S A Lewis; J I Evans
Journal:  Psychopharmacologia       Date:  1969

4.  Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients.

Authors:  S H Curry; J H Marshall
Journal:  Life Sci       Date:  1968-01-01       Impact factor: 5.037

5.  Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine.

Authors:  L E Hollister; S H Curry; J E Derr; S L Kanter
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

6.  Factors affecting chlorpromazine plasma levels in psychiatric patients.

Authors:  S H Curry; J M Davis; D S Janowsky; J H Marshall
Journal:  Arch Gen Psychiatry       Date:  1970-03

7.  The physiological disposition of chlorpromazine in the rat and dog.

Authors:  S H Curry; J E Derr; H M Maling
Journal:  Proc Soc Exp Biol Med       Date:  1970-05

8.  Inter-patient variation in chlorpromazine metabolism.

Authors:  D E Green; I S Forrest; F M Forrest; M T Serra
Journal:  Exp Med Surg       Date:  1965
  8 in total
  17 in total

1.  Plasma level studies in psychotropic evaluation.

Authors:  S H Curry
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  Tardive dyskinesia and pimozide.

Authors:  A C Gibson
Journal:  Proc R Soc Med       Date:  1977

3.  Treatment of chronic schizophrenia.

Authors:  D A Johnson
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

Review 4.  Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.

Authors:  C E Hansen; N E Larsen
Journal:  Psychopharmacologia       Date:  1974-06-18

6.  Mute of malady.

Authors: 
Journal:  Br Med J       Date:  1973-03-31

7.  Serum levels of thioridazine in psychiatric patients and healthy volunteers.

Authors:  E Mårtensson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

8.  Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.

Authors:  D J Boullin; H F Woods; R P Grimes; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

9.  Chlorpromazine-induced histamine release from guinea-pig skin in vitro--a photosensitive reaction.

Authors:  S K Lam; D R Tomlinson
Journal:  Arch Dermatol Res       Date:  1976-06-21       Impact factor: 3.017

10.  Chlorpromazine metabolism. IX. Pharmacokinetics of chlorpromazine following oral administration in man.

Authors:  L R Whitfield; P N Kaul; M L Clark
Journal:  J Pharmacokinet Biopharm       Date:  1978-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.